ZA201805547B - Novel antigen for use in malaria vaccine - Google Patents
Novel antigen for use in malaria vaccineInfo
- Publication number
- ZA201805547B ZA201805547B ZA2018/05547A ZA201805547A ZA201805547B ZA 201805547 B ZA201805547 B ZA 201805547B ZA 2018/05547 A ZA2018/05547 A ZA 2018/05547A ZA 201805547 A ZA201805547 A ZA 201805547A ZA 201805547 B ZA201805547 B ZA 201805547B
- Authority
- ZA
- South Africa
- Prior art keywords
- malaria vaccine
- novel antigen
- antigen
- novel
- malaria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662296464P | 2016-02-17 | 2016-02-17 | |
| PCT/US2017/017722 WO2017142843A1 (en) | 2016-02-17 | 2017-02-13 | Novel antigen for use in malaria vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201805547B true ZA201805547B (en) | 2023-01-25 |
Family
ID=59559460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2018/05547A ZA201805547B (en) | 2016-02-17 | 2018-08-20 | Novel antigen for use in malaria vaccine |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10195260B2 (2) |
| EP (1) | EP3416681B1 (2) |
| JP (2) | JP7261013B2 (2) |
| KR (1) | KR20180108754A (2) |
| CN (1) | CN109069607A (2) |
| AU (1) | AU2017219613B2 (2) |
| BR (1) | BR112018016912A2 (2) |
| CA (1) | CA3014196A1 (2) |
| WO (1) | WO2017142843A1 (2) |
| ZA (1) | ZA201805547B (2) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3416681B1 (en) | 2016-02-17 | 2026-01-21 | DayLife LLC | Novel antigen for use in malaria vaccine |
| CN110703326B (zh) * | 2019-10-11 | 2021-07-16 | 中国石油化工股份有限公司 | 一种基于中小偏移距道集的fvo反演方法 |
| US12485166B2 (en) | 2020-02-06 | 2025-12-02 | Longhorn Vaccines And Diagnostics, Llc | Vaccines for the treatment and prevention of zoonotic infections |
| WO2022003999A1 (en) * | 2020-06-29 | 2022-01-06 | Path | Pre-erythrocytic malaria vaccines |
| KR20230091978A (ko) | 2020-10-20 | 2023-06-23 | 롱혼 백신즈 앤드 다이어그나스틱스, 엘엘씨 | 면역원성 항원 |
| EP4590331A1 (en) | 2022-09-23 | 2025-07-30 | BioNTech SE | Compositions for delivery of plasmodium csp antigens and related methods |
| WO2024063788A1 (en) | 2022-09-23 | 2024-03-28 | BioNTech SE | Compositions for delivery of malaria antigens and related methods |
| JP2025533541A (ja) | 2022-09-23 | 2025-10-07 | ビオンテック・ソシエタス・エウロパエア | 肝病期抗原の送達のための組成物及び関連方法 |
| WO2024063789A1 (en) | 2022-09-23 | 2024-03-28 | BioNTech SE | Compositions for delivery of malaria antigens and related methods |
| EP4669348A1 (en) | 2023-02-24 | 2025-12-31 | BioNTech SE | IMMUNOGENEOUS COMPOSITIONS |
| CN121816193A (zh) | 2023-07-21 | 2026-04-07 | 生物技术欧洲股份公司 | 用于递送疟原虫抗原的组合物及相关方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101863970B (zh) * | 2010-05-18 | 2012-09-12 | 吉林大学 | 一种可抑制恶性疟原虫侵入的抗Pf332-DBL区单克隆抗体 |
| US9884101B2 (en) * | 2010-11-09 | 2018-02-06 | The Walter And Eliza Hall Institute For Medical Research | Treatment and prevention of malaria |
| WO2013108272A2 (en) * | 2012-01-20 | 2013-07-25 | International Centre For Genetic Engineering And Biotechnology | Blood stage malaria vaccine |
| GB201318084D0 (en) | 2013-10-11 | 2013-11-27 | Isis Innovation | Malaria vaccination |
| EP3416681B1 (en) | 2016-02-17 | 2026-01-21 | DayLife LLC | Novel antigen for use in malaria vaccine |
-
2017
- 2017-02-13 EP EP17753691.9A patent/EP3416681B1/en active Active
- 2017-02-13 AU AU2017219613A patent/AU2017219613B2/en active Active
- 2017-02-13 CN CN201780012190.0A patent/CN109069607A/zh active Pending
- 2017-02-13 BR BR112018016912A patent/BR112018016912A2/pt not_active Application Discontinuation
- 2017-02-13 WO PCT/US2017/017722 patent/WO2017142843A1/en not_active Ceased
- 2017-02-13 US US15/431,609 patent/US10195260B2/en active Active
- 2017-02-13 JP JP2018544178A patent/JP7261013B2/ja active Active
- 2017-02-13 CA CA3014196A patent/CA3014196A1/en active Pending
- 2017-02-13 KR KR1020187024980A patent/KR20180108754A/ko active Pending
-
2018
- 2018-08-20 ZA ZA2018/05547A patent/ZA201805547B/en unknown
- 2018-12-21 US US16/230,512 patent/US11793868B2/en active Active
-
2021
- 2021-12-10 JP JP2021200524A patent/JP2022037078A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019505560A (ja) | 2019-02-28 |
| JP2022037078A (ja) | 2022-03-08 |
| US20170232091A1 (en) | 2017-08-17 |
| WO2017142843A8 (en) | 2018-09-07 |
| CN109069607A (zh) | 2018-12-21 |
| EP3416681B1 (en) | 2026-01-21 |
| EP3416681A1 (en) | 2018-12-26 |
| CA3014196A1 (en) | 2017-08-24 |
| AU2017219613B2 (en) | 2022-04-07 |
| JP7261013B2 (ja) | 2023-04-19 |
| US10195260B2 (en) | 2019-02-05 |
| US20190117752A1 (en) | 2019-04-25 |
| AU2017219613A1 (en) | 2018-08-30 |
| EP3416681A4 (en) | 2020-03-18 |
| KR20180108754A (ko) | 2018-10-04 |
| BR112018016912A2 (pt) | 2018-12-26 |
| WO2017142843A1 (en) | 2017-08-24 |
| US11793868B2 (en) | 2023-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201805547B (en) | Novel antigen for use in malaria vaccine | |
| IL253187A0 (en) | New vaccines based on multivalent nanoparticles | |
| GB201410971D0 (en) | Vaccine | |
| GB201518684D0 (en) | Vaccine | |
| ZA201701461B (en) | Antibody formulations | |
| ES2648672T5 (en) | Improved hvt-vectored nd-ibd vaccine | |
| IL251469A0 (en) | Vaccines for the AIDS virus containing antigens of one or more of the Apisenses population | |
| IL268431A (en) | Antibodies useful in passive influenza vaccination, and compositions, combinations and methods for using them | |
| GB201400819D0 (en) | Mycobacterial antigen composition | |
| IL266237A (en) | Tolerogenic DNA composition | |
| HRP20200217T1 (hr) | Mutantni stafilokoni antigeni | |
| GB201522132D0 (en) | Vaccine | |
| IL252644A0 (en) | Vaccines based on jaundice core antigens b | |
| GB201616904D0 (en) | Vaccine | |
| IL247295A0 (en) | Components based on antigens with a yellow core b | |
| GB201608821D0 (en) | Vaccines | |
| GB201603625D0 (en) | Novel influenza antigens | |
| GB201415602D0 (en) | Streptococcal antigens | |
| PT3297666T (pt) | Adjuvante e vacina molecular | |
| PT3188755T (pt) | Vacina | |
| GB201603029D0 (en) | Vaccine | |
| GB201417214D0 (en) | Vaccine | |
| GB201406628D0 (en) | Vaccine | |
| GB201718337D0 (en) | Malaria vaccine | |
| GB201712092D0 (en) | Malaria vaccine |